State Street’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11M | Buy |
375,728
+88,372
| +31% | +$2.59M | ﹤0.01% | 2540 |
|
|
2025
Q1 | $7.39M | Sell |
287,356
-206,960
| -42% | -$5.32M | ﹤0.01% | 2708 |
|
|
2024
Q4 | $14.3M | Buy |
494,316
+205,162
| +71% | +$5.92M | ﹤0.01% | 2423 |
|
|
2024
Q3 | $6.86M | Buy |
289,154
+45,600
| +19% | +$1.08M | ﹤0.01% | 2810 |
|
|
2024
Q2 | $4.21M | Buy |
243,554
+178,410
| +274% | +$3.08M | ﹤0.01% | 3000 |
|
|
2024
Q1 | $1.45M | Buy |
65,144
+3,077
| +5% | +$68.7K | ﹤0.01% | 3380 |
|
|
2023
Q4 | $1.14M | Sell |
62,067
-285
| -0.5% | -$5.23K | ﹤0.01% | 3457 |
|
|
2023
Q3 | $1.08M | Sell |
62,352
-643
| -1% | -$11.2K | ﹤0.01% | 3512 |
|
|
2023
Q2 | $1.15M | Buy |
62,995
+50,259
| +395% | +$915K | ﹤0.01% | 3561 |
|
|
2023
Q1 | $218K | Hold |
12,736
| – | – | ﹤0.01% | 4050 |
|
|
2022
Q4 | $296K | Buy |
12,736
+5,957
| +88% | +$138K | ﹤0.01% | 3948 |
|
|
2022
Q3 | $150K | Hold |
6,779
| – | – | ﹤0.01% | 4262 |
|
|
2022
Q2 | $130K | Sell |
6,779
-39,277
| -85% | -$753K | ﹤0.01% | 4398 |
|
|
2022
Q1 | $1.64M | Buy |
46,056
+9,416
| +26% | +$336K | ﹤0.01% | 3643 |
|
|
2021
Q4 | $3.19M | Buy |
36,640
+8,548
| +30% | +$744K | ﹤0.01% | 3468 |
|
|
2021
Q3 | $3.22M | Buy |
+28,092
| New | +$3.22M | ﹤0.01% | 3460 |
|